The new data found that patients identified as low risk by the test received fewer biopsies and were less likely to be diagnosed later with high-grade prostate cancer.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.
Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test
Research companies Curta and Qure Healthcare will be conducting an economic modeling and physician behavior study, respectively.
The team's method is based on isolating and analyzing exosomes from tears to study and validate biomarkers for different diseases.
UCLA researchers developed an extracellular vesicle-based surface protein assay for early-stage hepatocellular carcinoma.